Anthropic has acquired the stealth biotech AI company Coefficient Bio in a $400 million stock transaction, as reported by The Information and Eric Newcomer. Insiders familiar with the agreement confirmed to TechCrunch that it was finalized, yet they refrained from commenting on the specifics of the financial terms.

This acquisition aligns with Anthropic’s ongoing expansion into healthcare and life sciences, following the October announcement of Claude for Life Sciences, a platform designed to assist scientific researchers in making discoveries.

Coefficient Bio’s founders, Samuel Stanton and Nathan C. Frey, established the startup eight months prior, both of whom have experience in computational drug discovery at Genentech’s Prescient Design. Coefficient Bio was leveraging AI to enhance the efficiency of drug discovery and various forms of biological research.

The team, comprising about 10 members, is anticipated to integrate into Anthropic’s health and life sciences division.